Sharon Bio-Medicine Q1, Q2, Q3, Q4, FY 2016-17, FY 2015-16 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Sharon Bio-Medicine Company Profile :

Sharon Bio-Medicine Limited is an Indian based holding company engaged in the development, manufacture and commercialization of pharmaceutical products under three segments: Active Pharma Ingredients (API’s), Formulations and Toxicology.

Company offers various Active Pharmaceutical Ingredients, including Ketoconazole, Trimetazidine Di HCI, Glimepiride, Eperisone HCI, Memantine HCI, Telmisartan, Nifedipine, Aripiprazole and Atomoxetine HCI. Company offers various intermediate products, including Cis Bromo Benzoate, N-Acetyl-4(4-Hydroxy Phenyl) Piperazine, Cis Tosylate and Tri Ethyl Benzyl Ammonium Chloride.

Company also offers various services, including preclinical toxicology on small animals, chemical process development and scale up, formulation development, analytical method development, drug master file (DMF) and dossier preparation, and commercial manufacturing of intermediates, actives and finished dosages.


Sharon Bio-Medicine Ltd ResultsBSE Code : 532908
NSE Symbol : SHARONBIO
ISIN No. : INE028B01029
Industry :  Pharmaceuticals
Face Value : Rs. 2.00


If you are an investor who has shares of Sharon Bio-Medicine or you are an stock market analyst then i am sure you might for Quarterly Results of Sharon Bio-Medicine.

In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of Sharon Bio-Medicine. That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of Sharon Bio-Medicine.

Sharon Bio-Medicine Q1 Results 2016-17 :

Sharon Bio-Medicine will announce its Q1 FY 2016-17 Results in the month of July 2016. We will update the table below once the results are announced.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Sharon Bio-Medicine will announce its Q2 FY 2016-17 Results in the month of October 2016.

Sharon Bio-Medicine will announce its Q3 FY 2016-17 Results in the month of January 2017.

Sharon Bio-Medicine will announce its Q4 FY 2016-17 Results in the month of April 2017.

Sharon Bio-Medicine will announce its FY 2016-17 Results in the month of April 2017.

Note : We will update the results table above as and when results are announced. Visit again.

Sharon Bio-Medicine Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue 253.46 253.45
Other Income  1.95  1.94
Total Income  255.40  255.39
Expenditure  -458.65  -34.09
Interest  -70.98  -70.98
Depreciation  -15.02  -15.01
PBT  -289.24  -290.30
Tax  -9.97  -9.96
Net Profit  -299.20  -300.26
Equity  23.79  23.79
EPS  -25.16  -25.25

Note : If you like this information about Sharon Bio-Medicine Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.